Kiplinger Kiplinger
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

From $107.88 $24.99

Subscribe to Kiplinger

  • Retirement Retirement
      • Retirement
        • View all Retirement
        • Annuities
        • Estate Planning
        • Retirement Plans
        • Social Security
        • Medicare
  • Investing Investing
      • Investing
        • View all Investing
        • Stocks
        • ETFs
        • Mutual Funds
        • Bonds
        • Wealth Management
        • AI
  • Taxes Taxes
      • Taxes
        • View all Taxes
        • Tax Returns
        • Tax Deductions
        • Capital Gains Taxes
        • State Taxes
        • Tax Planning
  • Personal Finance Personal Finance
      • Personal Finance
        • View all Personal Finance
        • Savings
        • Shopping and Deals
        • Credit Cards
        • Insurance
        • Money-saving
        • Banking
  • Life Life
      • Life
        • View all Life
        • Places to Live
        • Real Estate
        • Travel
        • Careers
        • Politics
        • Business
  • Adviser Intel
  • More
    • Kiplinger Puzzles
    • Kiplinger Economic Forecasts
  • Newsletters
    • Newsletter sign-up
    • Manage my newsletters
    • Latest issue of Kiplinger Today
    • Latest issue of Closing Bell
  • Subscriptions
    • Subscriptions Store
    • My Subscriptions
    • Subscriptions Help
    • Kiplinger Personal Finance
    • The Kiplinger Letter
    • The Kiplinger Tax Letter
    • Kiplinger Investing for Income
    • Kiplinger Retirement Report
    • Kiplinger Retirement Planning
  • Newsletter sign up Newsletter
  • Trending
    • Best Cash Cows to Buy
    • September Fed Meeting Live
    • Wealth Adviser's Guide to the OBBB's Impact on Retirement
    • IRS Updates Capital Gains Tax Thresholds

    When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

    AstraZeneca (AZN)

    Latest

    null

    Stock Market Today 10/13/20: Another Vaccine-Trial Stumble Clips Wall Street's Optimism

    stocks Johnson & Johnson (JNJ) paused a vaccine study, and Eli Lilly (LLY) was forced to do the same on a treatment trial, hampering stocks Tuesday.

    stocks
    • null

      Stock Market Today 9/9/20: Nasdaq Comes to Life in Raucous Rebound

      Markets The Nasdaq reversed course from its quickest-ever correction with sizable gains Wednesday, led by the usual suspects.

      By Kyle Woodley Published 9 September 20

      Markets
    • null

      Stock Market Today 8/24/20: FDA Gives Stocks a Booster Shot

      Markets The FDA's emergency-use green light of a COVID-19 treatment helped give the major indices a lift Monday, with the Dow leading the way.

      By Kyle Woodley Published 24 August 20

      Markets
    • null

      Two Good Dividend Stocks Yielding More Than 4%

      investing A drugmaker and an MLP promise attractive payouts to investors yearning for better yields.

      By Daren Fonda Published 20 July 16

      investing
    1 2
    Kiplinger Logo
    • About Us
    • Contact Future's experts
    • Terms and Conditions
    • Privacy Policy
    • Cookie Policy
    • Advertise with us

    Kiplinger is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.

    © Future US, Inc. Full 7th Floor, 130 West 42nd Street, New York, NY 10036.